
Lesley Rees
et al.
Published online:
01 March 2019
Published in print:
01 February 2019
Online ISBN:
9780191826863
Print ISBN:
9780198784272
Contents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The classification of paediatric vasculitis The classification of paediatric vasculitis
-
Background to classification criteria Background to classification criteria
-
Paediatric vasculitis classification 2010 Paediatric vasculitis classification 2010
-
General scheme for the classification of paediatric vasculitides General scheme for the classification of paediatric vasculitides
-
-
Investigation of primary systemic vasculitis Investigation of primary systemic vasculitis
-
Background Background
-
Characteristic features of individual vasculitides Characteristic features of individual vasculitides
-
Level 1 investigations Level 1 investigations
-
Haematology and acute phase reactants Haematology and acute phase reactants
-
Basic biochemistry Basic biochemistry
-
Infectious disease screen Infectious disease screen
-
Immunological tests Immunological tests
-
Radiological Radiological
-
Other Other
-
-
Level 2 investigations Level 2 investigations
-
-
The standard treatment of childhood vasculitis The standard treatment of childhood vasculitis
-
Standard vasculitis therapy (excluding crescentic glomerulonephritis) Standard vasculitis therapy (excluding crescentic glomerulonephritis)
-
Other points of note Other points of note
-
Use of biological therapy in systemic vasculitis of the young Use of biological therapy in systemic vasculitis of the young
-
Further reading Further reading
-
-
-
Further reading Further reading
-
Henoch–Schönlein purpura Henoch–Schönlein purpura
-
Epidemiology Epidemiology
-
Pathogenesis Pathogenesis
-
Clinical features of Henoch–Schönlein purpura Clinical features of Henoch–Schönlein purpura
-
Henoch–Schönlein purpura nephritis Henoch–Schönlein purpura nephritis
-
Pathological findings in Henoch–Schönlein purpura Pathological findings in Henoch–Schönlein purpura
-
Investigation of Henoch–Schönlein purpura Investigation of Henoch–Schönlein purpura
-
Differential diagnosis Differential diagnosis
-
Who needs a renal biopsy? Who needs a renal biopsy?
-
General treatment of Henoch–Schönlein purpura General treatment of Henoch–Schönlein purpura
-
Treatment of Henoch–Schönlein purpura nephritis Treatment of Henoch–Schönlein purpura nephritis
-
Treatment with oral prednisolone to prevent development of Henoch–Schönlein purpura nephritis Treatment with oral prednisolone to prevent development of Henoch–Schönlein purpura nephritis
-
Rapidly progressive glomerulonephritis Rapidly progressive glomerulonephritis
-
Treatment of Henoch–Schönlein purpura nephritis that is not rapidly progressive Treatment of Henoch–Schönlein purpura nephritis that is not rapidly progressive
-
Use of ACE inhibitors in Henoch–Schönlein purpura nephritis Use of ACE inhibitors in Henoch–Schönlein purpura nephritis
-
-
Long-term outcome of Henoch–Schönlein purpura Long-term outcome of Henoch–Schönlein purpura
-
Recurrence of Henoch–Schönlein purpura in renal allografts Recurrence of Henoch–Schönlein purpura in renal allografts
-
Further reading Further reading
-
-
-
Further reading Further reading
-
Kawasaki disease Kawasaki disease
-
Pathogenesis and epidemiology Pathogenesis and epidemiology
-
Diagnostic criteria Diagnostic criteria
-
Clinical features Clinical features
-
Differential diagnosis Differential diagnosis
-
Infections Infections
-
Drug reactions Drug reactions
-
Rheumatic diseases Rheumatic diseases
-
Malignancy Malignancy
-
-
Investigations Investigations
-
Investigations for differential diagnosis Investigations for differential diagnosis
-
-
Treatment Treatment
-
Outcome Outcome
-
-
Polyarteritis nodosa Polyarteritis nodosa
-
Background Background
-
Aetiology Aetiology
-
Clinical features Clinical features
-
Differential diagnosis Differential diagnosis
-
Diagnostic laboratory and radiological investigation Diagnostic laboratory and radiological investigation
-
Blood tests Blood tests
-
Tissue biopsy Tissue biopsy
-
Radiological tests Radiological tests
-
-
Treatment Treatment
-
Outcome Outcome
-
Further reading Further reading
-
-
-
Further reading Further reading
-
The antineutrophil cytoplasmic antibody-associated vasculitides The antineutrophil cytoplasmic antibody-associated vasculitides
-
Background Background
-
Definitions of antineutrophil cytoplasmic antibody-associated vasculitides Definitions of antineutrophil cytoplasmic antibody-associated vasculitides
-
Pathogenesis Pathogenesis
-
Clinical features of granulomatosis with polyangiitis Clinical features of granulomatosis with polyangiitis
-
Organ-specific involvement Organ-specific involvement
-
-
Investigations Investigations
-
Treatment of antineutrophil cytoplasmic antibody-associated vasculitides Treatment of antineutrophil cytoplasmic antibody-associated vasculitides
-
Outcome of antineutrophil cytoplasmic antibody-associated vasculitides Outcome of antineutrophil cytoplasmic antibody-associated vasculitides
-
Further reading Further reading
-
-
-
Further reading Further reading
-
Takayasu arteritis Takayasu arteritis
-
Background Background
-
Epidemiology Epidemiology
-
Aetiopathogenesis Aetiopathogenesis
-
Histopathology Histopathology
-
Clinical features Clinical features
-
Acute phase Acute phase
-
Chronic phase Chronic phase
-
Eye involvement Eye involvement
-
Renal involvement Renal involvement
-
-
Differential diagnoses Differential diagnoses
-
Infectious causes Infectious causes
-
-
Laboratory investigations Laboratory investigations
-
Imaging Imaging
-
Diagnosis Diagnosis
-
Treatment Treatment
-
Hypertension Hypertension
-
Revascularization and other surgical procedures Revascularization and other surgical procedures
-
Techniques Techniques
-
Indications for revascularization Indications for revascularization
-
-
Prognosis Prognosis
-
Further reading Further reading
-
-
-
Further reading Further reading
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cite
Rees, Lesley, and others, 'Vasculitis', Paediatric Nephrology, 3 edn, Oxford Specialist Handbooks in Paediatrics (Oxford , 2019; online edn, Oxford Academic, 1 Mar. 2019), https://doi.org/10.1093/med/9780198784272.003.0011, accessed 3 May 2025.
Abstract
This chapter describes the presentation, investigation, and management of children with vasculitis.
Disclaimer
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct.
Readers must therefore always …
More
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct.
Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets
provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or
legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages
and recommendations are for the non-pregnant adult who is not breastfeeding.
© Oxford University Press
You do not currently have access to this chapter.
Sign in
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Purchase
Our books are available by subscription or purchase to libraries and institutions.
Purchasing informationMetrics
View Metrics
Metrics
Total Views
34
22
Pageviews
12
PDF Downloads
Since 10/1/2022
Month: | Total Views: |
---|---|
October 2022 | 1 |
February 2023 | 2 |
June 2023 | 2 |
September 2023 | 2 |
November 2023 | 4 |
January 2024 | 2 |
March 2024 | 2 |
May 2024 | 1 |
June 2024 | 3 |
July 2024 | 2 |
August 2024 | 2 |
September 2024 | 4 |
November 2024 | 6 |
December 2024 | 1 |
Citations
Altmetrics
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.